KLF10 and metabolic disease: Since KLF10-knockout mice exhibited a high incidence of metabolic disorders, we previously explored sirtuin6, an NAD+-dependent deacetylase downstream of KLF10, as a key regulator of glucose homeostasis and a tumor suppressor.